Related Experiment Video
Updated: Sep 13, 2025
Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
A Bayesian network analysis of the Pfizer COVID-19 vaccine in the paediatric population
Tej Shukla1, Helen J Mayfield2, John C B Litt3
1Guy's and St Thomas' NHS Foundation Trust, London, UK. Shuklatd@gmail.com.
Insights
The Pfizer COVID-19 vaccine poses a lower myocarditis risk for teenage males than infection. COVID-19 vaccination offers population benefits by preventing hospitalizations and MIS-C, especially at higher transmission rates.
Area of Science:
- Immunology
- Public Health
- Epidemiology
Background:
- The Pfizer COVID-19 vaccine is linked to increased myocarditis risk.
- COVID-19 infection itself carries significant health risks and complications.
Purpose of the Study:
- To compare myocarditis risk from Pfizer vaccination versus COVID-19 infection in pediatric populations.
- To evaluate population-level benefits of the Pfizer vaccine in mitigating severe outcomes.
Main Methods:
- Utilized a Bayesian network (BN) model.
- Incorporated Australian and international data.
- Compared vaccine-associated, COVID-19 infection, and background myocarditis rates, alongside hospitalization and MIS-C risks.
Main Results:
- Teenage males face a 4.47 times higher risk of myocarditis from COVID-19 infection compared to vaccination.
- Unvaccinated individuals showed higher risks for hospitalization and MIS-C across all age groups.
- Population-level analysis indicated vaccine benefits in preventing severe outcomes were dependent on age, transmission rates, and vaccination coverage.
Conclusions:
- COVID-19 infection presents a greater myocarditis risk than the Pfizer vaccine for teenage males.
- The Pfizer vaccine provides significant population-level benefits in reducing hospitalizations and MIS-C, particularly in high-transmission scenarios.
- Vaccine benefits are nuanced, varying with demographic factors and epidemiological context.
Abstract:
The Pfizer COVID-19 vaccines have been associated with an increased risk of myocarditis. However, COVID-19 infection is also associated with complications. A Bayesian network (BN), informed by Australian and international data, was created to determine individual risks and benefits of the Pfizer COVID-19 vaccine in the paediatric. The risk of myocarditis between vaccine-associated, COVID-19 and background rates was compared, as well as secondary outcomes such as hospitalization, and MIS-C. At a population level, hospitalizations, intensive care admissions and MIS-C cases prevented at differing transmission rates and vaccine coverage were analyzed. The model estimated that teenage males were 4.47 times more likely to develop myocarditis from COVID-19 compared to the vaccine. Furthermore, the risk of hospitalizations and MIS-C were more likely in the unvaccinated cohort for all ages. The population level benefits of COVID-19 Pfizer vaccine at mitigating myocarditis are more nuanced, contingent on age, transmission rates and vaccination coverage.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
01:25Statistical Methods for Analyzing Epidemiological Data
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...